Novavax Sells 60 Million Doses of Its Coronavirus Vaccine to the U.K. Government
In a Securities and Exchange Commission filing on Wednesday, Novavax (NASDAQ: NVAX) disclosed that the U.K. government had agreed to purchase 60 million doses of NVX-CoV2372, its COVID-19 vaccine candidate. The deal also gives the U.K. the option to make additional orders "from time to time."
A price per dose for the initial order wasn't disclosed by the biotech. Typically, additional orders would come at a higher price per dose, but the differential wasn't disclosed either.
As part of the agreement, Novavax agreed to create a dedicated supply chain in the U.K. for the production of that country's order. The company will be required to deliver those 60 million doses to the U.K. government before using that supply chain to fulfill orders for any other parties unless the U.K. government gives it permission.
Source Fool.com
